These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

239 related items for PubMed ID: 35028605

  • 21. Formalin-inactivated Coxiella burnetii phase I vaccine-induced protection depends on B cells to produce protective IgM and IgG.
    Zhang G, Peng Y, Schoenlaub L, Elliott A, Mitchell W, Zhang Y.
    Infect Immun; 2013 Jun; 81(6):2112-22. PubMed ID: 23545296
    [Abstract] [Full Text] [Related]

  • 22. Contributions of lipopolysaccharide and the type IVB secretion system to Coxiella burnetii vaccine efficacy and reactogenicity.
    Long CM, Beare PA, Cockrell DC, Fintzi J, Tesfamariam M, Shaia CI, Heinzen RA.
    NPJ Vaccines; 2021 Mar 19; 6(1):38. PubMed ID: 33741986
    [Abstract] [Full Text] [Related]

  • 23. Components of protective immunity.
    Zhang G, Zhang Y, Samuel JE.
    Adv Exp Med Biol; 2012 Mar 19; 984():91-104. PubMed ID: 22711628
    [Abstract] [Full Text] [Related]

  • 24. Coxiella burnetii antigen-stimulated dendritic cells mediated protection against Coxiella burnetii in BALB/c mice.
    Wei Y, Wang X, Xiong X, Wen B.
    J Infect Dis; 2011 Jan 15; 203(2):283-91. PubMed ID: 21288829
    [Abstract] [Full Text] [Related]

  • 25. Chloroform-Methanol Residue of Coxiella burnetii Markedly Potentiated the Specific Immunoprotection Elicited by a Recombinant Protein Fragment rOmpB-4 Derived from Outer Membrane Protein B of Rickettsia rickettsii in C3H/HeN Mice.
    Gong W, Wang P, Xiong X, Jiao J, Yang X, Wen B.
    PLoS One; 2015 Jan 15; 10(4):e0124664. PubMed ID: 25909586
    [Abstract] [Full Text] [Related]

  • 26. Vaccines against coxiellosis and Q fever. Development of a chloroform:methanol residue subunit of phase I Coxiella burnetti for the immunization of animals.
    Williams JC, Peacock MG, Waag DM, Kent G, England MJ, Nelson G, Stephenson EH.
    Ann N Y Acad Sci; 1992 Jun 16; 653():88-111. PubMed ID: 1626897
    [Abstract] [Full Text] [Related]

  • 27. Comparative efficacy of a Coxiella burnetii chloroform:methanol residue (CMR) vaccine and a licensed cellular vaccine (Q-Vax) in rodents challenged by aerosol.
    Waag DM, England MJ, Pitt ML.
    Vaccine; 1997 Nov 16; 15(16):1779-83. PubMed ID: 9364683
    [Abstract] [Full Text] [Related]

  • 28. Coxiella burnetii Epitope-Specific T-Cell Responses in Patients with Chronic Q Fever.
    Scholzen A, Richard G, Moise L, Hartman E, Bleeker-Rovers CP, Reeves PM, Raju Paul S, Martin WD, De Groot AS, Poznansky MC, Sluder AE, Garritsen A.
    Infect Immun; 2019 Oct 16; 87(10):. PubMed ID: 31331958
    [Abstract] [Full Text] [Related]

  • 29. Attenuated Coxiella burnetii phase II causes a febrile response in gamma interferon knockout and Toll-like receptor 2 knockout mice and protects against reinfection.
    Ochoa-Repáraz J, Sentissi J, Trunkle T, Riccardi C, Pascual DW.
    Infect Immun; 2007 Dec 16; 75(12):5845-58. PubMed ID: 17893129
    [Abstract] [Full Text] [Related]

  • 30. Identification of CD4+ T cell epitopes in C. burnetii antigens targeted by antibody responses.
    Chen C, Dow C, Wang P, Sidney J, Read A, Harmsen A, Samuel JE, Peters B.
    PLoS One; 2011 Mar 15; 6(3):e17712. PubMed ID: 21423609
    [Abstract] [Full Text] [Related]

  • 31. Guinea pig abscess/hypersensitivity model for study of adverse vaccination reactions induced by use of Q fever vaccines.
    Wilhelmsen CL, Waag DM.
    Comp Med; 2000 Aug 15; 50(4):374-8. PubMed ID: 11020154
    [Abstract] [Full Text] [Related]

  • 32. Tuning Subunit Vaccines with Novel TLR Triagonist Adjuvants to Generate Protective Immune Responses against Coxiella burnetii.
    Gilkes AP, Albin TJ, Manna S, Supnet M, Ruiz S, Tom J, Badten AJ, Jain A, Nakajima R, Felgner J, Davies DH, Stetkevich SA, Zlotnik A, Pearlman E, Nalca A, Felgner PL, Esser-Kahn AP, Burkhardt AM.
    J Immunol; 2020 Feb 01; 204(3):611-621. PubMed ID: 31871024
    [Abstract] [Full Text] [Related]

  • 33. Development of a lipopolysaccharide-targeted peptide mimic vaccine against Q fever.
    Peng Y, Zhang Y, Mitchell WJ, Zhang G.
    J Immunol; 2012 Nov 15; 189(10):4909-20. PubMed ID: 23053512
    [Abstract] [Full Text] [Related]

  • 34. Immunisation with purified Coxiella burnetii phase I lipopolysaccharide confers partial protection in mice independently of co-administered adenovirus vectored vaccines.
    Dold C, Zhu H, Silva-Reyes L, Blackwell L, Linder A, Bewley K, Godwin K, Fotheringham S, Charlton S, Kim YC, Pollard AJ, Rollier CS.
    Vaccine; 2023 May 05; 41(19):3047-3057. PubMed ID: 37037709
    [Abstract] [Full Text] [Related]

  • 35. Coxiella burnetii Lipopolysaccharide: What Do We Know?
    Abnave P, Muracciole X, Ghigo E.
    Int J Mol Sci; 2017 Nov 23; 18(12):. PubMed ID: 29168790
    [Abstract] [Full Text] [Related]

  • 36. Mice immunized with bone marrow-derived dendritic cells stimulated with recombinant Coxiella burnetii Com1 and Mip demonstrate enhanced bacterial clearance in association with a Th1 immune response.
    Xiong X, Meng Y, Wang X, Qi Y, Li J, Duan C, Wen B.
    Vaccine; 2012 Nov 06; 30(48):6809-15. PubMed ID: 23000126
    [Abstract] [Full Text] [Related]

  • 37. Coxiella burnetii interaction with neutrophils and macrophages in vitro and in SCID mice following aerosol infection.
    Elliott A, Peng Y, Zhang G.
    Infect Immun; 2013 Dec 06; 81(12):4604-14. PubMed ID: 24082077
    [Abstract] [Full Text] [Related]

  • 38. Identification and cloning potentially protective antigens of Coxiella burnetii using sera from mice experimentally infected with Nine Mile phase I.
    Zhang GQ, Samuel JE.
    Ann N Y Acad Sci; 2003 Jun 06; 990():510-20. PubMed ID: 12860683
    [Abstract] [Full Text] [Related]

  • 39. Characterization of a phase I Coxiella burnetii chloroform-methanol residue vaccine that induces active immunity against Q fever in C57BL/10 ScN mice.
    Williams JC, Damrow TA, Waag DM, Amano K.
    Infect Immun; 1986 Mar 06; 51(3):851-8. PubMed ID: 3949384
    [Abstract] [Full Text] [Related]

  • 40. Antibody-mediated immunity to the obligate intracellular bacterial pathogen Coxiella burnetii is Fc receptor- and complement-independent.
    Shannon JG, Cockrell DC, Takahashi K, Stahl GL, Heinzen RA.
    BMC Immunol; 2009 May 08; 10():26. PubMed ID: 19426498
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.